1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastasesnon-small cell lung carcinomaNot yet recruitingPhase 22026-02-17NCT07413952